Tribute to Ozzy Osbourne

We are deeply saddened to hear of the passing of Ozzy Osbourne, an icon who bravely shared his journey with Parkinson’s disease. His openness helped bring much-needed visibility to this complex condition.

At Harness Therapeutics, we are committed to advancing new treatments for neurodegenerative diseases like Parkinson’s. Today, we honour Ozzy’s legacy and stand in solidarity with all those affected.

Learn more about Parkinson’s disease here.

#ParkinsonsAwareness #OzzyOsbourne #Neurodegeneration

Our programmes

Huntington's Disease

ALS and Alzheimer's

Our news

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

Read more

February 2025

Harness Therapeutics to Present Nanopore Sequencing Data for Detecting CAG Expansion in the Huntingtin Gene at CHDI Huntington’s Disease Therapeutics Conference

Read more

January 2025

Harness Therapeutics appoints Dr Heather Preston as Chair and secures new funding from Ono Venture Investment to accelerate delivery of transformational neurodegeneration pipeline

Read more

September 2024

Harness Therapeutics Appoints Experienced R&D Executive and Physician-Scientist, Dr Paulo Fontoura, as Non-Executive Director

Read more